Identi®cation or prediction of coding sequences from within genomic DNA has been a major rate-limiting step in the pursuit of genes. Programs currently available are far from being powerful enough to elucidate the gene structure completely. In this paper, we develop eective hidden Markov models (HMMs) to represent the consensus and degeneracy features of splicing junction sites in eukaryotic genes. Our HMM system based on the developed HMMs is fully trained using an expectation maximization (EM) algorithm and the system performance is evaluated using a 10-way cross-validation method. Experimental results show that the proposed HMM system can correctly detect 92% of the true donor sites and 91.5% of the true acceptor sites in the test data set containing real vertebrate gene sequences. These results suggest that our approach provide a useful tool in discovering the splicing junction sites in eukaryotic genes. Ó
1. Introduction
Background
A deoxyribonucleic acid (DNA) chain is a long, unbranched polymer composed of four types of nucleotides or bases: adenine (A), cytosine (C), guanine (G) and thymine (T). Genes, made of DNA, are the invisible information-containing elements that are distributed to each daughter cell when a cell divides. In general, genes are divided into two categories: eukaryotic and prokaryotic. Eukaryotic genes are from eukaryotic cells and prokaryotic genes are from prokaryotic cells.``Eu'' means``good, well or true''.``Karyote'' (or`c aryote'') means``nucleus'' (``caryon'' in Greek). A eukaryotic cell, by de®-nition, has a nucleus that contains the cell's DNA for all of its genes, enclosed by a double layer of membrane [1] . So, the eukaryotic gene category includes all kinds of genes from cells with a nucleus, such as those from any kind of animals, even yeast.
In the bioinformatics ®eld, eukaryotic DNA (or gene) means the kind of genomic DNA with introns, such as the DNA from high level animals and human. Prokaryotic cells, in contrast to the eukaryotic cells, have relatively simple internal structures, speci®cally, without membrane enclosed nuclei [1] . Prokaryotic cells include those from the various types of bacteria such as E. coli. E. coli has simple genomic DNA and its cells are very easy to culture. So, E. coli is often used for research on prokaryotic DNA.
The basic gene structure for higher eukaryotes includes promoter, start codon, introns, exons, and stop codon, etc. (see Fig. 1 ). The exon sequences of a gene are also called the coding sequences of this gene, and the whole exon sequences of a gene are called the coding region of the gene (which is the region for making protein). In contrast, prokaryotic genes have no introns, and the gene structure includes only promoter, start codon, coding region and stop codon. Normally, if one can detect the promoter in a prokaryotic DNA sequence, one is able to ®nd its gene coding region. Intron sequences range in size from about 80 nucleotides to 10 000 nucleotides or more. Introns in genes are of no function at all and are actually the genetic``junk'' [1] . They dier dramatically from exons in that their exact nucleotide sequences seem to be unimportant. The only highly conserved sequences in introns are those required for intron removal.
The genetic information present in genes is expressed in organisms (gene expression) through the processes of transcription and translation (see Fig. 1 ). Transcription is the process for the production of a speci®c molecule, namely messenger RNA (mRNA), from a given sequence of DNA in a gene [3, 4] . In this process, the genetic information (message) carried in the DNA is transcribed to (or written into) the mRNA. As its name implies, messenger RNA carries a message. The process by which mRNA directs the synthesis of a speci®c protein is called translation. In this process, the information (message) carried in the mRNA sequence is translated into the amino acid sequence of the protein.
In the eukaryotic gene transcription process, the intermediate product is called pre-mRNA. Pre-mRNA is a direct copy of the DNA sequence in the eukaryotic gene and it contains the exon and intron sequences from the gene. The intron sequences will be removed from pre-mRNA, so a mature mRNA only consists of exon sequences, which will be translated into protein. The process for intron removal is called RNA splicing, and the positions for intron removal and RNA rejoining are called splicing junction sites (see Fig. 1 ). The consensus sequences at each end of an intron are nearly the same in all known H donor sites, and the boundaries between the introns and the exons are called 3 H acceptor sites. During the DNA transcription process, the gene sequences (excluding the promoter region) are ®rst transcribed into pre-mRNA.Then, the intron sequences in the pre-mRNA are removed and the RNA fragments are rejoined together by the RNA splicing process to get mRNA. The mRAN directs protein synthesis through the gene translation process.
intron sequences. The conserved boundary sequence at the 5 H splice site is called a donor site, and the one at the 3 H splice site is called an acceptor site. The donor site and acceptor site are collectively referred to as splicing junction sites. The RNA breaking and rejoining (splicing) must be carried out precisely because an error of even one nucleotide would shift the reading frame in the resulting mRNA molecule and make nonsense of its message [1] .
A bioinformatics approach
Identi®cation or prediction of coding sequences from within a genomic DNA sequence has been a major rate-limiting step in the pursuit of genes. For eukaryotic gene detection, we have to detect the start codon, exons, introns and stop codon. How to ®nd out exons/introns? The most important step is to detect splicing junction sites including donor and acceptor sites, because once the splicing junction sites are detected, the exon/intron boundaries are found. Then we can remove the introns from the DNA sequence to get coding regions. Biologists study gene structures based on lab experiments such as PCR on cDNA libraries, Northern blot, sequencing, etc. However, characterizing the 60 000±100 000 genes thought to be hidden in the human genome by means of merely lab experiments is not feasible. A current trend is to complement the lab study with a bioinformatics approach.
The bioinformatics approach for gene detection means using computer programs to elucidate a gene structure from DNA sequence signals, including start codon, splicing junction donor sites and acceptor sites, stop codon, etc. Since 1990s, a number of programs have been developed for locating gene coding regions (exons). However, the vertebrate DNA sequence signals involved in gene determination are usually ill de®ned, degenerate and highly unspeci®c. Given the current detection methods it is usually impossible to distinguish the signals truly processed by the cellular machinery from those that are apparently nonfunctional [8] . Furthermore, the inherent conservatism of the currently popular methods such as similarity search, GRAIL, etc., greatly limits our ability for making unexpected biological discoveries from increasingly abundant genomic data. Except for a very limited subset of trivial cases, the automated interpretation without experimental validation of genomic data is still a myth [7] . Unlike the situation in bacteria and yeast organisms, in which computer systems have substantially contributed to the automatic analysis of genomes, automatic sequence analysis and structure elucidation for the genomes of high eukaryotic organisms are far from being a reality [8] .
Our research is targeted toward developing eective and accurate methods for identifying gene structures in the genomes of high eukaryotic organisms. The ®rst phase of our research, introduced in this paper, is for gene structure signal detection. Then, during the second phase, we will combine the gene structure signal information with global gene structure information to develop a full gene structure detection system. Splicing junction donor and acceptor sites are the most important functional gene structure signals. Earlier we developed a Motif model and used pattern matching techniques for donor prediction [12, 13] . We also reported our case studies and preliminary results for predicting splicing junction acceptors [14±16] . In this paper, we systematically introduce our approach that uses hidden Markov models (HMMs) to represent the degeneracy features of the splicing junction sites. We developed TEM, an EM-like algorithm, to train our HMM system. Then we use the 10-way crossvalidation method to evaluate our system for detecting splicing junction sites in unlabeled DNA sequences.
HMMs have been used extensively to describe sequential data or processes such as speech recognition. Researchers in computational biology have recently started to use HMMs for biological sequence analysis. Lukashin, Borodovsky [10] and their colleagues [5] successfully applied HMMs to the detection of protein coding regions in prokaryote. Audic and Claverie [2] reported their use of Markov transition matrices to detect eukaryotic promoters. Salzberg [11] used HMMs to identify splice junction sites and translational start sites in eukaryotic genes; his group also developed an HMM system, called Viterbi exon±intron locator (VEIL), for ®nding eukaryotic genes [9] . Our approach diers from Salzberg's by using a dierent topology of HMMs and by employing two modules for implementing the HMMs: one for true sites, and the other for false sites. Even though the current systems are far from being powerful enough for gene structure elucidation, the information these researchers provide is valuable, and the research on automated gene detection using HMMs is of great potentiality.
Using HMMs to model splicing junction sites

The Donor Model
Splicing junction sites in vertebrate DNA include donor and acceptor sites. Donor sites are conserved boundary sequences at the 5 H splicing sites in DNA. The conserved sequences include 9 nucleotide bases with GT (GU in mRNA) almost invariable to all donor sites [1] . An example of a donor site is shown below:
The nucleotide G occurs at position 4 and the nucleotide T occurs at position 5 in a donor site. We refer to a 9-base sequence that exists as a donor in a real gene sequence as a true donor site. Note that in all true donor sites, G and T occur at position 4 and position 5, respectively. We refer to a 9-base nondonor sequence in which G and T also occur at position 4 and position 5, respectively, as a false donor site. Notice that we do not consider those sequences without G, T being at position 4 and position 5, respectively, because they are deemed to be nondonor sequences. Given an unlabeled 9-base sequence with G, T being at position 4 and position 5, respectively, referred to as a candidate donor site, our algorithm tries to determine whether the candidate sequence is a true donor site or a false donor site. We design a Donor Model, de®ned below, based on HMMs to describe the consensus and degenerate properties occurring in true donor sites.
An HMM with 9 states and a set of transitions is used for modeling a true donor site, which is represented as a digraph where states correspond to vertices and transitions to edges. At each state, the HMM generates a base b in {A, G, C, T} according to the state and transition probabilities, with the exception of state 4 and state 5. At state 4, the HMM constantly generates base b G, and at state 5, the HMM constantly generates base b T. Each state s is associated with a discrete probability distribution, P s. For state 4 and state 5, P s 1. Except at state 3 and state 4, each base b at a state has four possible transitions to the next state. Each transition has a probability, P t, which represents the probability that the HMM makes that transition. Each base at state 3 has a ®xed transition, namely P t 1, to the base G at state 4. Similarly, at state 4, the base G has a ®xed transition, namely P t 1, to the base T at state 5. Fig. 2 illustrates the Donor Model.
The Acceptor Model
Acceptor sites are conserved boundary sequences at the 3 H splicing sites in DNA. The conserved sequences include 16 nucleotide bases with AG almost invariable to all acceptor sites [1] . An example of an acceptor site is shown below:
The nucleotide A occurs at position 14 and the nucleotide G occurs at position 15 in an acceptor site. We refer to a 16-base sequence that exists as an acceptor in a real gene sequence as a true acceptor site. Note that in all true acceptor sites, A and G occur at position 14 and position 15, respectively. We refer to a 16-base nonacceptor sequence in which A and G also occur at position 14 and position 15, respectively, as a false acceptor site. Given an unlabeled 16-base sequence with A, G being at position 14 and position 15, respectively, referred to as a candidate acceptor site, our algorithm tries to determine whether the candidate sequence is a true acceptor site or a false acceptor site. We use an Acceptor Model, de®ned below, to describe the consensus and degenerate properties occurring in true acceptor sites.
An HMM with 16 states and a set of transitions is developed for modeling a true acceptor site, which is represented as a digraph where states correspond to vertices and transitions to edges. At each state, the HMM generates a base b in {A, G, C, T} according to the state and transition probabilities, with the exception of state 14 and state 15. At state 14, the HMM constantly generates base b A, and at state 15, the HMM constantly generates base b G. Each state s is associated with a discrete probability distribution, P s. For state 14 and state 15, P s 1. Except at state 13 and state 14, each base b at a state has four possible transitions to the next state. Each transition has a probability, P t, which represents the probability that the HMM makes that transition. Each base at state 13 has a ®xed transition, namely P t 1, to the base A at state 14. Similarly, at state 14, the base A has a ®xed transition, namely P t 1, to the base G at state 15. Fig. 3 illustrates the Acceptor Model. There are 16 states in this model. Except state 14 and state 15, there are four possible bases at each state, and a base at one state may have four possible ways to transit to the next state. States 14 and 15 are a constant, and the transition from state 14 to state 15 is also a constant with a probability of 1. In a gene sequence, states 1±15 belong to an intron and state 16 is the ®rst base of an exon. 
Two modules for each model
In vertebrate DNA sequences, there are much more false splicing junction sites than true sites. The ratio between the number of false sites and the number of true sites is about 100±1. In order to mine out the dierences between the true sites and false sites, we implement two programs, True Donor Module and False Donor Module, based on the Donor Model and another two programs, True Acceptor Module and False Acceptor Module, based on the Acceptor Model. The True Donor Module and True Acceptor Module are collectively referred to as true site modules. The False Donor Module and False Acceptor Module are collectively referred to as false site modules. We train the true site modules using the true sites in the training data set, and train the false site modules using the false sites in the training data set. A given candidate site is tested by these modules. Let S cand be a candidate site. Let P Y 1 j S cand ; M t be the probability of S cand being a donor (acceptor) sequence given that it is processed by a true site module. Let P Y 0 j S cand ; M f be the probability of S cand being a nondonor (nonacceptor) sequence given that it is processed by a false site module. In the above speci®cation, M t is for the true site modules and M f is for the false site modules. In the splicing junction detection phase, these true site modules and false site modules are used to classify candidate sequences into right categories. For example, for a candidate donor site, we ®rst pass it through True Donor Module to get P Y 1 j S cand ; M t , the probability of this candidate site being a donor sequence. Then we pass it through False Donor Module to get P Y 0 j S cand ; M f , the probability of this candidate site being a nondonor sequence. Comparing these two values, we assign a score to the candidate sequence. This candidate sequence is assigned to the true donor category or false donor category depending on its score obtained.
Algorithms
The algorithms described in this section can be used for both the Donor Model and the Acceptor Model. For illustration purposes, we focus on the Donor Model and its corresponding modules, True Donor Module and False Donor Module. The algorithms for the Acceptor Model are essentially the same.
Training algorithm
We develop a modi®ed expectation maximization (EM) algorithm, called TEM, for training the modules. The original EM method takes, as the input, a set of unaligned sequences and a motif length, and returns a probabilistic model for the motif [3] . Because our data set contains splicing junction sites with the same length, and all these sites can be aligned to each other, we design TEM speci®cally for training a HMM with ®xed topology.
Let M represent the set of sequences that are randomly picked from our positive training data set and negative training data set. (In the study presented here, M contains about 200 true donor sites and 14 000 false donor sites.) Each sequence in M is labeled as positive or negative depending on whether it is from the positive training data set or the negative training data set. Let E t be the set containing the remaining sequences in the positive training data set, and let E f represent the set containing the remaining sequences in the negative training data set. There are much more true (false, respectively) donor sites in E t (E f , respectively) than those in M. (In our study presented here, the total number of the sequences in E t and E f is about nine times of the number of sequences in M.) Let P be a subset of M.
In the training phase, the TEM algorithm proceeds iteratively to converge. At each iteration, the algorithm removes some sequences from E t and E f and inputs those sequences into True Donor Module and False Donor Module. The algorithm then uses these modules to determine which sequences are placed in P as we will explain later. We use S em n to represent the sensitivity and use S em p to represent the speci®city during the TEM training. S em n is the ratio between the number of true donor sites in P and the total number of true donor sites in M; note that P M. S em p is the ratio between the number of true donor sites in P and the total number of sequences in P. The goal of our TEM training is, given a ®xed value of S em n , we train the modules iteratively to get a maximal value of S em p , or until E t and E f become empty. In this research, we use S em n 0:90 for training the modules.
Speci®cally 
Next, we treat all the sequences in M as unlabeled sequences and input them into True Donor Module and False Donor Module. Let P True j S; M t denote the probability of a sequence S in set M being a donor sequence, and let P False j S; M f denote the probability of S being a nondonor sequence. In order to calculate P True j S; M t , we must calculate the probability of the sequence S given the sequence is a true donor site using True Donor Module. This can be written as
; b i P fA; G; C; Tg: 3
Our TEM algorithm uses Bayes' rule to estimate P True j S; M t from P S j True; M t . Bayes' rule states that
so, P True j S; M t P S j True; M t P True P S : 5 P True is the prior probability that is assumed to be a constant, and P S is the product of the individual base probabilities in the sequences. P S can be written as
In the same way, we can write equations for calculating P False j S; M f as follows:
Let pratio be the probability ratio of sequence S in set M, and pratio P True j S; M t P False j S; M f : 10
The pratio is calculated for each sequence in set M. We then sort the sequences in set M, in the descending order, according to their pratio values. Suppose the total number of positive sequences in set M is N. Then we select the pratio value for the N Â S em n th positive sequence and use that pratio value as the positive lower bound, denoted L p . (In the study presented here, there are 200 positive sequences in set M and the sensitivity S em n is 0.9. Therefore, L p is the pratio value of the 180th positive sequence in set M.) The TEM algorithm assigns a sequence S P M into set P if the pratio value for S is greater than or equal to L p . Let T TP be the number of positive sequences in set M that are assigned into set P. Let T P N be the total number of positive sequences in M. Then, by de®nition,
Let T PP be the total number of sequences in M that are assigned into P. Then, by de®nition,
The re-estimation procedure then adjusts all of the probabilities hidden in the Donor Model in order to increase S em p . New sequences in E t and E f are picked and removed from E t and E f . These sequences are then run through True Donor Module and False Donor Module again and the probabilities are further re®ned. This process is iterated until the S em p is maximized or until E t and E f become empty. This algorithm is guaranteed to converge to a locally optimal estimate of all the probabilities in the Donor Model. The positive lower bound L p that maximizes S em p will be an output and used in the splicing junction sites detection phase. Fig. 4 summarizes the TEM algorithm used in the training phase.
Algorithm for detecting splicing junction sites
As described in Section 2, a candidate donor site refers to a 9-base sequence fragment with bases G, T being at position 4 and position 5, respectively. The input of the site detection algorithm is a fragment, denoted S cand , of 9 bases extracted from a genomic DNA sequence S with a minimum length of 9 bases. In this research, the longest DNA sequence used is about 50 000 bases long. The S cand has G, T at position 4 and 5, respectively, and is considered as a candidate donor site. We refer to the 9 bases in S cand as b 1 ; b 2 ; . . . ; b 9 , respectively. The output of the site detection algorithm is a¯ag, KIND i , indicating whether the S cand starting at positing i of the genomic DNA sequence S is a true donor site or not.
Let f tr t j b j ; b j1 be the probability of a transition from base b j to base b j1 , 1 6 j 6 8, of S cand using True Donor Module. We de®ne a¯ag variable Y to be 1 if S cand belongs to a true site category, and 0 otherwise. Let n be the length of the candidate site S cand (n is 9 for donor sites and 16 for acceptor sites). Let P S cand jY 1; M t be the probability of the candidate site S cand given that it is a donor site processed by True Donor Module. Then
f tr t j b j ; b j1 ; b j P fA; G; C; Tg: 13
As de®ned before, P Y 1 j S cand ; M t is the probability of S cand being a donor site given that it is processed by True Donor Module. According to Bayes' rule [cf. Eq. (4) 
When examining a set of sequences to detect true donor sites, we can treat the underlying prior P Y 1 as a constant [11] . P S cand is the product of the individual base probabilities for b 1 ; b 2 ; . . . ; b n in S cand :
Similarly, we use False Donor Module to compute P Y 0 j S cand ; M f , the probability of S cand being a false donor site given that it is processed by False Donor Module. So, we can write the false donor site counterparts of the above equations:
; b j P fA; G; C; Tg; 16
Given the candidate donor site S cand starting at position i in the genomic DNA sequence S, our algorithm will ®nd the two most likely sets of states through the two HMM modules for S cand . Then the algorithm calculates P Y 1 j S cand ; M t and P Y 0 j S cand ; M f . A score, sratio, is assigned to the candidate site based on the scoring function below:
Comparing sratio with the L p obtained from the training phase, we assign ā ag, KIND i , to the candidate site S cand based on the following formula:
The candidate site S cand is classi®ed as a true donor site if KIND i has a value of 1. S cand is classi®ed as a false donor site if KIND i has a value of 0. Fig. 5 illustrates the site detection algorithm.
Experiments and results
Sequence data and evaluation method
In order to evaluate the accuracy of our HMM system for splicing junction site detection, we used the database of DNA sequences originally collected by Burset and Guigo [6] , who used this database to compare a number of major gene-®nding programs. The sequences in this database were obtained from the vertebrate divisions of GenBank release 85.0 (October, 1994). There are 570 vertebrate sequences in the database and they all have simple and standard gene structures. Each entry contains a complete protein coding sequence with no inframe stop codons. There are at least one exon and one intron in all entries in the database. There are 2079 true donor sites and 2079 true acceptor sites, all of which are standard splicing junction sites. This means that all the donor sites have`GT' and all the acceptor sites have`AG' at the right positions. This database now becomes the standard data set for evaluating gene-®nding programs.
We applied the 10-way cross-validation method [14] to evaluate how well our HMM system performs when tested on data that are not in the training dataset. Cross-validation is a standard experimental technique for determining how well a classi®er performs on unseen data [9] . Speci®cally, we randomly partition the 570 sequences at hand into 10 sets. These sets have roughly the same number of true donor sites; the sets also have roughly the same number of true acceptor sites. For each iteration in the 10-way cross-validation experiment, we use nine out of the ten sets as the training data set, and use the remaining one set as the test data set. The HMM system is trained using the training data set (i.e., all sequences excluding those in the test data set are used as the training data). The system is then tested on the sequences in the test data set. Thus, the training data set consists of 90% and the test data set consists of 10% of the sequences. Each time in the 10-way cross-validation experiment, the HMM system is trained with sequences containing about 1871 true sites and 135 000 false sites. The HMM system is tested on the sequences containing about 208 true sites and 14 000 false sites.
Experimental results
The state transition probabilities for the Donor Model and the Acceptor Model are shown in Tables 1±4. Comparing the state transition probabilities of the true site modules with those of the false site modules, we see that the proposed HMM system maximizes the dierences between the true sites and false sites. The results for detecting splicing junction sites are summarized in Tables 5 and 6 . The results for each of the 10 test sets of the cross-validation The state transition probability values are of`double' type in our computer programs. In order to save space, the values are rounded to the second position following the decimal point to ®t into this table. For example, a probability value of 0.13293 is shown in this table as 0.13, but 0.13593 is shown here as 0.14. Theoretically, the sum of the transition probabilities from one state to the next state should equal to 1.00. Because of the rounding, the sum of the values in each column in this table may be slightly smaller or greater than 1.00. This holds in Tables 2±4 as well. are shown, so are the average results for all the 10 test sets. In Tables 5 and 6 , TP is the number of true positives. FP is the number of false positives. TN is the number of true negatives. FN is the number of false negatives. A true positive is a true donor (true acceptor, respectively) site that is also classi®ed as a true donor (true acceptor, respectively) site. A false positive is a false donor (false acceptor, respectively) site that is mis-classi®ed as a true donor (true acceptor, respectively) site. A true negative is a false donor (false acceptor, respectively) site that is also classi®ed as a false donor (false acceptor, respectively) site. A false negative is a true donor (true acceptor, respectively) site that is mis-classi®ed as a false donor (false acceptor, respectively) site. S true n is the ratio between the number of correctly classi®ed true donor (true acceptor, respectively) sites and the total number of true donor (true acceptor, respectively) sites in the test data set, i.e.,
We also did similar calculations to evaluate the performance of the proposed HMM system in predicting the false splicing junction sites. S false n is the ratio between the number of correctly classi®ed false donor (false acceptor, respectively) sites and the total number of false donor (false acceptor, respectively) sites in the test data set, i.e., Table 6 Performance evaluation of the proposed HMM system used in detecting acceptor sites where S n is the proportion of the candidate sites in the test data set that are classi®ed correctly. S n tells how well the proposed HMM system can assign true sites and false sites into the right categories; it is calculated by the following formula:
where N c is the number of the candidate sites in the test data set that are classi®ed correctly and N t is the total number of the candidate sites in the test data set.
The results in Table 5 show that, on average, our system can correctly detect 92% of the true donor sites in the test data set, and 95% of the false donor sites in the test data set are predicted as false sites. Overall, 95% of the candidate donor sites are classi®ed into the right categories. The results for acceptor classi®cation are shown in Table 6 . The proposed HMM system can correctly predict 91.5% of the true acceptor sites in the test data set and 93% of the false acceptor sites in the test data set. In general, the system can assign 93% of the candidate acceptor sites into the right categories.
To investigate how well the proposed HMM system can discriminate true splicing junction sites from false splicing junction sites when a group of candidate sequences are presented to the system, we performed some statistic analysis on the scores the HMM system assigned to each candidate site in the 10-way cross-validation experiment. Fig. 6 shows the score distribution of true donor sites and false donor sites in one test data set. Fig. 7 shows the score distribution of true acceptor sites and false acceptor sites in the same test data set. Striking dierences can be observed by comparing the curves in these ®gures. The scores for the true donor sites can be higher than 10 000, with about 85% of the true donor sites scoring more than 10. For the false donor sites, only about 5% of the sequences score more than 1, with the majority of the false donor sites scoring between 0.1 and 0.00001. More than 10% of the false donor sites score less than 0.00001. The score distribution for the true acceptor scores in Fig. 7 shares a similar pattern as the one for the true donor sites shown in Fig. 6 . The scores for the false acceptor sites are more scattered, but again, there are only 5±6% of the sequences scoring more than 1. The results suggest that the proposed HMM system can be used to discover the degenerate features of the splicing junction sites to a great degree.
Conclusions
In this paper we have developed HMMs to represent the consensus and degenerate features of splicing junction sites in eukaryotic genes. The proposed Donor Model and Acceptor Model have a dierent topology from those previously reported for splicing junction site detection. To capture the consensus and degenerate features of the splicing junction sites, we introduced constant states and constant state transitions into the HMMs. This innovative approach conceptually simpli®es the splicing junction site models and the computation process of using the models. The results from the 10-way crossvalidation experiment show that the proposed HMM system can correctly detect 92% of the true donor sites and 91.5% of the true acceptor sites in the standard sequence data set composed by Burset and Guigo. It is worth to point out that we only use the local information in the proposed Donor Model and Acceptor Model. When combining our HMM system with the global gene structure information, it is likely that one can achieve even better results for site recognition. This is the research underway in our group. Currently, we are trying to integrate our HMM system with other gene structure information to develop an eective and accurate system for full gene structure detection.
